CLINICAL_TRIALS
trial_result
· 2020-04-24
Clinical Trial Update: Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]
Summary
Phase 2 trial update for linaclotide in irritable bowel syndrome with constipation has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Irritable Bowel Syndrome With Constipation | Phase 2 | Status: COMPLETED | Results posted: 2020-04-24